SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION

Shanghai Shen Lian Biomedical Corporation

688098

CNE100003P17

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
5.3 ^CNY	-1.49%		-4.68%	-29.14%

May. 06	Shen Lian Biomedical Gets Certificate for Swine Fever Vaccine; Shares Up 3%	MT
Apr. 26	Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Shanghai Shen Lian Biomedical Corporation Announces Earnings Results for the Nine Months of 2020

October 27, 2020

Shanghai Shen Lian Biomedical Corporation announced earnings results for the nine months of 2020. For the nine months, the company announced basic earnings per share of CNY 0.34.

Latest news about Shanghai Shen Lian Biomedical Corporation

Shen Lian Biomedical Gets Certificate for Swine Fever Vaccine; Shares Up 3%	May. 06	MT
Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Shen Lian Biomedical Gets Nod for Two Pig Virus Detection Kits	Apr. 26	MT
Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Shen Lian Biomedical Obtains Production License, GMP Certificate	Nov. 21	MT
Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Shen Lian Biomedical Forms Tie-up to Develop African Swine Fever Vaccine	23-10-16	MT
Certain A Shares of Shanghai Shen Lian Biomedical Corporation are subject to a Lock-Up Agreement Ending on 16-OCT-2023.	23-10-15	CI
Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Shen Lian Biomedical Passes Regulatory Inspection	23-08-15	MT
Shen Lian Biomedical's Bovine Vaccine Passes Regulatory Evaluation	23-05-19	MT
Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Shanghai Shen Lian Biomedical Ties Up with Caremed Biomedical to Set Up Joint Venture	23-04-19	MT
Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Shen Lian Biomedical Gets Marketing Approval for Pig Vaccine in China	22-11-10	MT
Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Certain A Shares of Shanghai Shen Lian Biomedical Corporation are subject to a Lock-Up Agreement Ending on 16-OCT-2022.	22-10-15	CI
Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-27	CI
Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-20	CI
Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-25	CI
Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-25	CI
Tarsus Pharmaceuticals and LianBio Announce Strategic Partnership to Develop and Commercialize TP-03 in Greater China for the Treatment of Demodex Blepharitis and Meibomian Gland Disease	21-03-29	CI

Chart Shanghai Shen Lian Biomedical Corporation

Duration

Period

Chart Shanghai Shen Lian Biomedical Corporation

More charts

Shanghai Shen Lian Biomedical Corp is a China-based company mainly engaged in the research, development, production and sales of veterinary biological products. The Company is committed to the research & development of foot and mouth disease vaccines, which are used to protect animals from foot and mouth diseases. The Company's main product are swine foot and mouth disease vaccines, and it also provides cattle foot and mouth disease vaccines, other swine vaccines, and other veterinary diagnostic reagents. The Company mainly sells its products within domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION	-29.14%	301M
ZOETIS INC.	-13.83%	77.6B
ELANCO ANIMAL HEALTH INCORPORATED	+12.68%	8.3B
BLUESTAR ADISSEO COMPANY	+24.00%	3.67B
VIRBAC	+0.14%	3.27B
VIMIAN GROUP AB	+14.70%	1.67B
JINYU BIO-TECHNOLOGY CO., LTD.	-4.46%	1.59B
VETOQUINOL SA	+2.54%	1.35B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-22.01%	1.3B
WUHAN KEQIAN BIOLOGY CO.,LTD	-12.12%	1.15B

Veterinary Drugs